Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

MACC1 Expression Correlates with PFKFB2 and Survival in Hepatocellular Carcinoma

  • Ji, Dong (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Lu, Zhong-Tang (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Li, Yao-Qing (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Liang, Zhe-Yong (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Zhang, Peng-Fei (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Li, Chao (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Zhang, Jun-Li (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Zheng, Xin (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University) ;
  • Yao, Ying-Min (Department of Hepatobiliary Surgery, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University)
  • Published : 2014.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To validate the relationship between MACC1 and 6-phosphofructo-2-kinase/fructose 2, 6 bisphosphatase (PFKFB2) expression as well as its clinicopathological features and prognostic significance in hepatocellular carcinoma. Methods: By using immunohistochemistry, we investigated the MACC1 and PFKFB2 protein expression in 60 pairs of hepatocellular carcinoma and corresponding non-tumor tissues. Using the Mann-Whitney U test, the Chi-square test, Kaplan-Meier survival analysis, Cox proportional hazard regression analysis and Spearman analysis, we studied the relationship between MACC1 and PFKFB2 protein expression and postoperative overall survival (OS) of the HCC patients. Results: MACC1 and PFKFB2 positive staining rates were significantly higher in hepatocellular carcinoma than in the corresponding nontumor tissues (P=0.012 and 0.04, respectively). The clinicopathological features evaluation revealed that positive expression of MACC1 was associated with a high Edmondson classification (P=0.007) and advanced TNM stage (P=0.027). Similar findings were evident for PFKFB2 expression (P=0.002 and P=0.027). MACC1 and PFKFB2 positive expression was associated with a lower OS rate (P=0.004 and 0.03, respectively). Kaplan-Meier survival and Cox proportional hazard regression analyses revealed MACC1 positive expression to be a prognostic factor for postoperative OS, but PFKFB was not. Conclusion: Highly expressed MACC1 and PFKFB2 protein were associated with TNM stage, Edmondson-Steier classification and overall survival. MACC1 may affect tumor metabolism partly through expression and phophorylation of PFKFB2.

Keywords

References

  1. Bijur GN, Jope RS (2003). Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem, 87, 1427-35. https://doi.org/10.1046/j.1471-4159.2003.02113.x
  2. Blum R, Jacob-Hirsch J, Amariglio N, et al (2005). Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res, 65, 999-1006.
  3. Boardman LA (2009). Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer.. Genome medicine, 1, 36. https://doi.org/10.1186/gm36
  4. Bobarykina AY, Minchenko DO, Opentanova IL, et al (2006). Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Acta Biochim Pol, 53, 789-99.
  5. Bosca L, Mojena M, Ghysdael J (1986). Expression of the v-src or v-fps oncogene increases fructose 2, 6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. Biochem J, 236, 595-9.
  6. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  7. Gao, J, Ding F, Liu Q (2013). Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem, 376, 21-32. https://doi.org/10.1007/s11010-012-1545-y
  8. Gottlob K FAU Majewski N, Majewski N FAU Kennedy S, Kennedy S FAU Kandel E, et al (2001). - Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev, 15, 1406-18. https://doi.org/10.1101/gad.889901
  9. Kawauchi K, Araki K, Tobiume K, & Tanaka N (2008). p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol, 10, 611-8. https://doi.org/10.1038/ncb1724
  10. Kokoszynska K, Krynski J, Rychlewski L, et al (2009). Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochimica Polonica, 56, 317-323.
  11. Minchenko OH, Opentanova IL, Ogura T, et al (2005). Expression and hypoxia-respo -nsiveness of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 inmammary gland malignant cell lines. Acta Biochim Pol, 52, 881-8.
  12. Moon JS, Jin W J, Kwak, JH, et al (2011). Androgen stimulates glyco-lysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 in prostate cancer cells. Biochem J, 433, 225-33. https://doi.org/10.1042/BJ20101104
  13. Novellasdemunt L, Tato I, Navarro-Sabate A, et al (2013). Aktdependent activation of heart 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (PFKFB2) isoenzyme by amino acids. J Biol Chem, 288, 10640-51. https://doi.org/10.1074/jbc.M113.455998
  14. Neary CL FAU Pastorino JG, & Pastorino JG (2013). - Akt inhibition promotes hexokinase 2 redistribution and glucose uptake in cancer cells. J Cell Physiol, 228, 1943-8. https://doi.org/10.1002/jcp.24361
  15. Okar DA, Manzano A, Navarro-Sabate A, et al (2001). PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate. Trends Biochem Sci, 26, 30-35. https://doi.org/10.1016/S0968-0004(00)01699-6
  16. Pelicano H , Martin DS, Xu RH, & Huang P (2006). Glycolysis inhibition for anticancer treatment. Oncogene, 25, 4633-46. https://doi.org/10.1038/sj.onc.1209597
  17. Rider MH, Bertrand L, Vertommen D, et al (2004). 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J, 381, 561-79. https://doi.org/10.1042/BJ20040752
  18. Roberts DJ, Tan-Sah VP, Tan-Sah VP, et al (2013). Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem, 288, 32638. https://doi.org/10.1074/jbc.A113.482026
  19. Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B (2008). Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs, 17, 1533-45. https://doi.org/10.1517/13543784.17.10.1533
  20. Stein U, Smith J, Walther W, Arlt F (2009). MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle, 8, 2467-9. https://doi.org/10.4161/cc.8.15.9018
  21. Stein U, Walther W, Arlt F, et al (2009). MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med, 15, 59-67. https://doi.org/10.1038/nm.1889
  22. Van Schaftingen E (1987). Fructose 2, 6-bisphosphate. Adv Enzymol Relat Areas Mol Biol, 59, 315-95.
  23. WARBURG O (1956). On the origin of cancer cells. Science, 123, 309-314. https://doi.org/10.1126/science.123.3191.309
  24. Yalcin A, Clem BF, Simmons A, et al (2009). Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem, 284, 24223-32. https://doi.org/10.1074/jbc.M109.016816
  25. Zeller KI, Zhao X, Lee CW, et al (2006). Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci USA, 103, 17834-9. https://doi.org/10.1073/pnas.0604129103

Cited by

  1. Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4545
  2. Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese Patients vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.2979
  3. DEP Domain Containing 1 is a Novel Diagnostic Marker and Prognostic Predictor for Hepatocellular Carcinoma vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10917
  4. MACC1 overexpression and survival in solid tumors: a meta-analysis vol.36, pp.2, 2015, https://doi.org/10.1007/s13277-014-2736-9
  5. In silico discovery of significant pathways in colorectal cancer metastasis using a two-stage optimisation approach vol.9, pp.6, 2015, https://doi.org/10.1049/iet-syb.2015.0031
  6. Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II vol.2016, pp.1687-630X, 2016, https://doi.org/10.1155/2016/2139489
  7. Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors vol.102, pp.11, 2017, https://doi.org/10.1210/jc.2017-00881
  8. Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer vol.14, pp.4, 2017, https://doi.org/10.3892/ol.2017.6670
  9. SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway vol.9, pp.3, 2018, https://doi.org/10.1038/s41419-018-0419-y
  10. Fructose 2,6-Bisphosphate in Cancer Cell Metabolism vol.8, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2018.00331
  11. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study vol.15, pp.1, 2015, https://doi.org/10.1186/s12885-015-1150-z
  12. MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation vol.37, pp.4, 2018, https://doi.org/10.1007/s10555-018-9771-8
  13. Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients vol.9, pp.2234-943X, 2019, https://doi.org/10.3389/fonc.2019.00028